Click for best price
B Cell Maturation Antigen Targeted Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for B Cell Maturation Antigen Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B Cell Maturation Antigen Targeted Therapy. This report contains market size and forecasts of B Cell Maturation Antigen Targeted Therapy in global, including the following market information:
Global B Cell Maturation Antigen Targeted Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global B Cell Maturation Antigen Targeted Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antibody-Drug Conjugates Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of B Cell Maturation Antigen Targeted Therapy include GlaxoSmithKline, Johnson & Johnson, Amgen, Seagen, AbbVie, Novartis, BioTherapeutics, Celgene and Bluebird Bio, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the B Cell Maturation Antigen Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global B Cell Maturation Antigen Targeted Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, by Type, 2022 (%)
Antibody-Drug Conjugates
CAR-T Cells and Bispecific T Cell Engagers
Global B Cell Maturation Antigen Targeted Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global B Cell Maturation Antigen Targeted Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies B Cell Maturation Antigen Targeted Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies B Cell Maturation Antigen Targeted Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Johnson & Johnson
Amgen
Seagen
AbbVie
Novartis
BioTherapeutics
Celgene
Bluebird Bio
Bristol Mayer Squibb
Carsgen Therapeutics
Juno Therapeutics
Cogent Bioscience
CRISPR Therapeutics
Allogene Therapeutics
Harpoon Therapeutics
Poseida Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of B Cell Maturation Antigen Targeted Therapy, market overview.
Chapter 2: Global B Cell Maturation Antigen Targeted Therapy market size in revenue.
Chapter 3: Detailed analysis of B Cell Maturation Antigen Targeted Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of B Cell Maturation Antigen Targeted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
B Cell Maturation Antigen Targeted Therapy Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 B Cell Maturation Antigen Targeted Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global B Cell Maturation Antigen Targeted Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global B Cell Maturation Antigen Targeted Therapy Overall Market Size
2.1 Global B Cell Maturation Antigen Targeted Therapy Market Size: 2022 VS 2029
2.2 Global B Cell Maturation Antigen Targeted Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top B Cell Maturation Antigen Targeted Therapy Players in Global Market
3.2 Top Global B Cell Maturation Antigen Targeted Therapy Companies Ranked by Revenue
3.3 Global B Cell Maturation Antigen Targeted Therapy Revenue by Companies
3.4 Top 3 and Top 5 B Cell Maturation Antigen Targeted Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies B Cell Maturation Antigen Targeted Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Players in Global Market
3.6.1 List of Global Tier 1 B Cell Maturation Antigen Targeted Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global B Cell Maturation Antigen Targeted Therapy Market Size Markets, 2022 & 2029
4.1.2 Antibody-Drug Conjugates
4.1.3 CAR-T Cells and Bispecific T Cell Engagers
4.2 By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
4.2.1 By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
4.2.2 By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2024-2029
4.2.3 By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global B Cell Maturation Antigen Targeted Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
5.2.1 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
5.2.2 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2024-2029
5.2.3 By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global B Cell Maturation Antigen Targeted Therapy Market Size, 2022 & 2029
6.2 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
6.2.1 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2023
6.2.2 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2024-2029
6.2.3 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.3.2 US B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.3.3 Canada B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.3.4 Mexico B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.4.2 Germany B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.3 France B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.4 U.K. B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.5 Italy B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.6 Russia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.7 Nordic Countries B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.4.8 Benelux B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.5.2 China B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5.3 Japan B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5.4 South Korea B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5.5 Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.5.6 India B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.6.2 Brazil B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.6.3 Argentina B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029
6.7.2 Turkey B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.7.3 Israel B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
6.7.5 UAE B Cell Maturation Antigen Targeted Therapy Market Size, 2018-2029
7 B Cell Maturation Antigen Targeted Therapy Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.1.4 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.2.4 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.3.4 Amgen B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Seagen
7.4.1 Seagen Company Summary
7.4.2 Seagen Business Overview
7.4.3 Seagen B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.4.4 Seagen B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.4.5 Seagen Key News & Latest Developments
7.5 AbbVie
7.5.1 AbbVie Company Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.5.4 AbbVie B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.5.5 AbbVie Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.6.4 Novartis B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 BioTherapeutics
7.7.1 BioTherapeutics Company Summary
7.7.2 BioTherapeutics Business Overview
7.7.3 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.7.4 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.7.5 BioTherapeutics Key News & Latest Developments
7.8 Celgene
7.8.1 Celgene Company Summary
7.8.2 Celgene Business Overview
7.8.3 Celgene B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.8.4 Celgene B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.8.5 Celgene Key News & Latest Developments
7.9 Bluebird Bio
7.9.1 Bluebird Bio Company Summary
7.9.2 Bluebird Bio Business Overview
7.9.3 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.9.4 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.9.5 Bluebird Bio Key News & Latest Developments
7.10 Bristol Mayer Squibb
7.10.1 Bristol Mayer Squibb Company Summary
7.10.2 Bristol Mayer Squibb Business Overview
7.10.3 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.10.4 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.10.5 Bristol Mayer Squibb Key News & Latest Developments
7.11 Carsgen Therapeutics
7.11.1 Carsgen Therapeutics Company Summary
7.11.2 Carsgen Therapeutics Business Overview
7.11.3 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.11.4 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.11.5 Carsgen Therapeutics Key News & Latest Developments
7.12 Juno Therapeutics
7.12.1 Juno Therapeutics Company Summary
7.12.2 Juno Therapeutics Business Overview
7.12.3 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.12.4 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.12.5 Juno Therapeutics Key News & Latest Developments
7.13 Cogent Bioscience
7.13.1 Cogent Bioscience Company Summary
7.13.2 Cogent Bioscience Business Overview
7.13.3 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.13.4 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.13.5 Cogent Bioscience Key News & Latest Developments
7.14 CRISPR Therapeutics
7.14.1 CRISPR Therapeutics Company Summary
7.14.2 CRISPR Therapeutics Business Overview
7.14.3 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.14.4 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.14.5 CRISPR Therapeutics Key News & Latest Developments
7.15 Allogene Therapeutics
7.15.1 Allogene Therapeutics Company Summary
7.15.2 Allogene Therapeutics Business Overview
7.15.3 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.15.4 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.15.5 Allogene Therapeutics Key News & Latest Developments
7.16 Harpoon Therapeutics
7.16.1 Harpoon Therapeutics Company Summary
7.16.2 Harpoon Therapeutics Business Overview
7.16.3 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.16.4 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.16.5 Harpoon Therapeutics Key News & Latest Developments
7.17 Poseida Therapeutics
7.17.1 Poseida Therapeutics Company Summary
7.17.2 Poseida Therapeutics Business Overview
7.17.3 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.17.4 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2018-2023)
7.17.5 Poseida Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. B Cell Maturation Antigen Targeted Therapy Market Opportunities & Trends in Global Market
Table 2. B Cell Maturation Antigen Targeted Therapy Market Drivers in Global Market
Table 3. B Cell Maturation Antigen Targeted Therapy Market Restraints in Global Market
Table 4. Key Players of B Cell Maturation Antigen Targeted Therapy in Global Market
Table 5. Top B Cell Maturation Antigen Targeted Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global B Cell Maturation Antigen Targeted Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global B Cell Maturation Antigen Targeted Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies B Cell Maturation Antigen Targeted Therapy Product Type
Table 9. List of Global Tier 1 B Cell Maturation Antigen Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - B Cell Maturation Antigen Targeted Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 32. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 36. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 40. Amgen B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. Seagen Company Summary
Table 43. Seagen B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 44. Seagen B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Seagen Key News & Latest Developments
Table 46. AbbVie Company Summary
Table 47. AbbVie B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 48. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 52. Novartis B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. BioTherapeutics Company Summary
Table 55. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 56. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. BioTherapeutics Key News & Latest Developments
Table 58. Celgene Company Summary
Table 59. Celgene B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 60. Celgene B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Celgene Key News & Latest Developments
Table 62. Bluebird Bio Company Summary
Table 63. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 64. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Bluebird Bio Key News & Latest Developments
Table 66. Bristol Mayer Squibb Company Summary
Table 67. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 68. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Bristol Mayer Squibb Key News & Latest Developments
Table 70. Carsgen Therapeutics Company Summary
Table 71. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 72. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Carsgen Therapeutics Key News & Latest Developments
Table 74. Juno Therapeutics Company Summary
Table 75. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 76. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Juno Therapeutics Key News & Latest Developments
Table 78. Cogent Bioscience Company Summary
Table 79. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 80. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Cogent Bioscience Key News & Latest Developments
Table 82. CRISPR Therapeutics Company Summary
Table 83. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 84. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. CRISPR Therapeutics Key News & Latest Developments
Table 86. Allogene Therapeutics Company Summary
Table 87. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 88. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Allogene Therapeutics Key News & Latest Developments
Table 90. Harpoon Therapeutics Company Summary
Table 91. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 92. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Harpoon Therapeutics Key News & Latest Developments
Table 94. Poseida Therapeutics Company Summary
Table 95. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 96. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Poseida Therapeutics Key News & Latest Developments
List of Figures
Figure 1. B Cell Maturation Antigen Targeted Therapy Segment by Type in 2022
Figure 2. B Cell Maturation Antigen Targeted Therapy Segment by Application in 2022
Figure 3. Global B Cell Maturation Antigen Targeted Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global B Cell Maturation Antigen Targeted Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global B Cell Maturation Antigen Targeted Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by B Cell Maturation Antigen Targeted Therapy Revenue in 2022
Figure 8. By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 16. US B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 20. Germany B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 28. China B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Seagen B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Celgene B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
